Good Clinical Practices (GCP)

The Good Clinical Practices are an international quality standard that describes the conditions and processes under which research using clinical subjects (both human and animal) is conducted and that define the roles and responsibilities of clinical trial sponsors, investigators and monitors.

In the US, Clinical Trial research must be conducted in accordance with a series of federal regulations that provide for human subjects protection and privacy and ensures the transparency of human subject research results through the publication of trial information and results on an online registry and results database ( [Note: to register as a Study Record Manager (user) at, contact the QA.] These regulations have been internationally harmonized through the International Conference on Harmonization (ICH) who has prepared a detailed guidance document for Good Clinical Trials. Additionally, the International Committee of Medical Journal Editors (ICMJE) requires registration of all clinical trials (even non-interventional trials) as a condition of publication.

Additional guidance is also available for laboratories that conducted laboratory analysis in support of a clinical trial which are known as the Good Clinical Laboratory Practices (GCLP). Links can be found on the GCLP page.

GCP Training Opportunities

Regulatory Reference

Guidance Documents and Other Resources

Helpful Links

Medrio Clinical Trial Software – M-edu is CFR Part 11 compliant software with CloudEDC™ that is FREE for investigator-initiated trials.

Founded in San Francisco, CA, Medrio offers an integrated eClinical software platform with a fully hosted
Electronic Data Capture (EDC) system for all study phases. Medrio’s revolutionary CloudEDC™ technology features an easy-to-use drag-and-drop interface, allowing study managers to build their studies in days instead of months without any programming knowledge. Via its unique feature set, including events-based data collection, offline data entry, and PRO for the Phase I clinic, Medrio gives a special advantage to those performing early phase trials. It’s no wonder that 12 of the top 20 global pharmaceutical companies choose Medrio for their data collection needs.